Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach

In silico studies show that E. purpurea-derived compounds, especially Kaempferol 3-o-beta-d-glucopyranosyl-7-o-alpha-L-rhamnopyranoside, have better inhibitory potential against AXL and better pharmacokinetic profiles when compared with Foretinib. These compounds are thus proposed as novel AXL inhibitors for the treatment of breast cancer. Further, in vivo studies are needed to confirm the potency of the studied compounds.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-10-22
DOI
https://doi.org/10.1007/s12672-025-03541-9
Primary Topic
Nigella sativa pharmacological applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach

Toheeb A. Balogun, Abdulwasiu Ibrahim, Kayode Yomi Raheem, Timothy Oluwatimileyin Ayeni et al.
Discover Oncology
Nigella sativa pharmacological applications
article

Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach

Toheeb A. Balogun, Abdulwasiu Ibrahim, Kayode Yomi Raheem, Timothy Oluwatimileyin Ayeni, Daniel O. Nwankwo, Damilola S. Bodun, Ayomide Oluwadarasimi Adebesin, Opeyemi C. De Campos, Abass Abdulateef Ohilebo, Md. Ahad Ali, Saviour God’swealth Usin, O. S. Awotunde, Siham Lakrikh, Abdulsamad Omotayo Aiyelabegan, Cornelius Ayodeji Aboderin, Anas Haruna Ruggah
article en

Abstract

In silico studies show that E. purpurea-derived compounds, especially Kaempferol 3-o-beta-d-glucopyranosyl-7-o-alpha-L-rhamnopyranoside, have better inhibitory potential against AXL and better pharmacokinetic profiles when compared with Foretinib. These compounds are thus proposed as novel AXL inhibitors for the treatment of breast cancer. Further, in vivo studies are needed to confirm the potency of the studied compounds.

Discover OncologyVol. 16(1)
University of Notre Dame (US), Panacea Biotec (India) (IN), Fountain University (NG), University of San Diego (US), University of Ibadan (NG), Covenant University (NG), University of North Dakota (US), Adekunle Ajasin University (NG), University of Cross River State (NG), University of Kigali (RW), Osun State University (NG), University of California San Diego (US), Université Sultan Moulay Slimane (MA), Rwanda Biomedical Center (RW), Ambrose Alli University (NG), Usmanu Danfodiyo University (NG), University of Rajshahi (BD)
Université Sultan Moulay Slimane
Openalex Percentile: Top 53%
Nigella sativa pharmacological applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.